Food and Drug Administration
March 15, 2005
Slides
Tdap Introduction/Background/Presentation of Questions, Dr. Theresa Finn, PhD, FDA (HTM) (PPT)
BOOSTRIX™ GlaxoSmithKline (PPT) (PDF)
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (Boostrix™), Dr. Ann Schwartz, MD, FDA (HTM) (PPT)
ADACEL™ Introduction, Martha Monser, FDA (HTM) (PPT)
AP Tdap/ADCEL™, Aventis Pasteur, Ltd (PPT) (PDF)
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (Tdap, ADACEL™) Aventis Pasteur, Ltd., Dr. ChrisAnna Mink, MD, FDA (HTM) (PPT)
Open Public Hearing